𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RNA interference of LRRK2–microarray expression analysis of a Parkinson’s disease key player

✍ Scribed by K. Häbig; M. Walter; S. Poths; O. Riess; M. Bonin

Publisher
Springer
Year
2007
Tongue
English
Weight
635 KB
Volume
9
Category
Article
ISSN
1364-6745

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leucine-rich repeat kinase 2 (LRRK2): A
Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
✍ Payal N. Gandhi; Shu G. Chen; Amy L. Wilson-Delfosse 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years. Mutations in the gene encoding leucine‐rich repeat kinase‐2 (__LRRK2__) have recently been linked to autosomal dominant, late‐onset PD that is cl

Analysis of Lrrk2 R1628P as a risk facto
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
✍ Owen A. Ross; Yih-Ru Wu; Mei-Ching Lee; Manabu Funayama; Meng-Ling Chen; Alexand 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract Common genetic variants that increase the risk for Parkinson's disease may differentiate patient subgroups and influence future individualized therapeutic strategies. Herein we show evidence for __leucine‐rich repeat kinase 2 (LRRK2)__ c.4883G>C (R1628P) as a risk factor in ethnic Chine

Role of gene expression microarray analy
Role of gene expression microarray analysis in finding complex disease genes
✍ Chi C. Gu; D.C. Rao; Gary Stormo; Chindo Hicks; Michael A. Province 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

The promise of gene expression studies using microarray technology has inspired much new hope for finding complex diseases genes. It has become clear that complex diseases result from collective actions of many genetic and nongenetic factors. Therefore, genetic dissection of complex diseases should